Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-036974

CEO and CFO bought 1,000 shares at $9.07 ($9,070)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-10-10 Purchase +1,000 $9.07 $9,070 5,299,177 D
Open-market purchases · 1,000 sh · avg $9.07 · $9,070
Loading xslF345X05/ownership.xml…